|
|
Vice President – Greenwich, Connecticut
|
 |
Josh Richardson is a Vice President at Longitude Capital. He focuses on investments in biotechnology.
Prior to joining Longitude Capital in 2011, Dr. Richardson was an Engagement Manager with McKinsey & Company. While at McKinsey, he worked in the Pharmaceutical and Private Equity practices serving clients across a variety of areas including mergers and acquisitions, strategy, sales and marketing, and operations.
Dr. Richardson holds an M.D. from the University of Virginia and a B.S. (magna cum laude) in biomedical science from the University of South Florida.
He is involved with the team’s investment in Cadence Pharmaceuticals (NASDAQ: CADX).
|
|
|
|
